-
Life Tech Capital Reports On NovaBay's NeutroPhase
Tuesday, April 19, 2011 - 9:12am | 171Read More...According to Life Tech Capital, NovaBay Pharmaceuticals (NYSE: NBY) presented a poster on the efficacy of NeutroPhase (NVC-101) solution with Pioneer Technology's (private) hydrophobic mesh Sorbact in healing chronic non-healing wounds at the 2011 Symposium on Advanced Wound Care (SAWC) in Dallas...

